(Furue et al., 2018) Recently, the potential attenuation of skin inflammation in an IL-23-induced psoriasis mouse model was investigated by functional inhibition of IL-36R, which confirmed that functional activation of IL-36R was also one of the driving forces of psoriasis (Su et al., 2019). Here, IL1RL2 is linked to psoriasis.